Skip to main content

Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow Healthcare Conference.

Wedbush PacGrow Healthcare Conference
1x1 Investor Meetings: August 8-9, 2023
Location: Lotte Palace Hotel, New York, NY

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  233.06
+6.56 (2.90%)
AAPL  267.26
-3.75 (-1.38%)
AMD  221.08
-2.39 (-1.07%)
BAC  56.89
+0.94 (1.68%)
GOOG  317.32
+2.00 (0.63%)
META  658.79
+8.38 (1.29%)
MSFT  472.85
-0.09 (-0.02%)
NVDA  188.12
-0.73 (-0.39%)
ORCL  192.59
-3.12 (-1.59%)
TSLA  451.67
+13.60 (3.10%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.